FDA updates safety rules for new medical and digital devices
FDA updates safety rules for new medical and digital devices
Food and Drug Administration (FDA) has announced a significant shift in its regulatory strategy for digital health.
In a move to foster innovation, the agency is streamlining rules for low-risk digital health tools.
As of early 2026, software providing clinical decision support and general wellness wearables face fewer hurdles, provided they avoid medical-grade diagnostic claims.
This "pro-innovation" pivot aims to cut red tape for developers of consumer technology.
However, the FDA is simultaneously taking a stricter "safety-first" approach regarding cybersecurity.
Under new mandates, manufacturers of any software-enabled medical device must now provide a detailed Software Bill of Materials (SBOM) and prove cybersecurity throughout the product lifecycle.
These rules treat vulnerabilities as critical threats to patient safety.
By distinguishing between simple wellness apps and complex life-critical technology, the FDA is redefining its oversight to match the modern digital landscape.
